
Work Here?
Viome Life Sciences offers personalized nutrition and gut-health solutions by analyzing the microbiome and cellular health through health tests. Using mRNA technology and AI, it translates these results into individualized diet plans and supplement recommendations, including probiotics. Revenue comes from selling health tests, personalized supplements, and probiotic subscriptions. Its edge lies in combining microbiome data with cellular insights and applying AI-driven, ongoing personalized wellness guidance to help people optimize health.
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series D
Total Funding
$214M
Headquarters
Bellevue, Washington
Founded
2016
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$214M
Below
Industry Average
Funded Over
8 Rounds
Industry standards
Health Insurance
Company Equity
Seattle-area longevity startups Viome Life Science and Circulate Health are merging. Viome acquired Circulate for between $15 million and $50 million, though specifics were not disclosed. Viome sells at-home test kits for saliva, blood, and stool samples, offering personalised supplements based on results. It has also developed RNA biomarker diagnostics, including an oral and throat cancer test with FDA breakthrough designation. Circulate provides therapeutic plasma exchange services through specially trained nurses, aiming to remove inflammatory factors and aging-associated compounds from blood. The combined company has 115 full-time employees and 10 consultants. Most Circulate staff retained their positions. The merger could expand their reach from 40 clinics to 400 sites. Circulate raised $14 million before acquisition. Viome, founded a decade ago, has raised approximately $250 million. Both microbiome testing and plasma exchange face questions regarding scientific evidence supporting their health benefit claims.
Viome will integrate its extensive dataset of human and microbial gene expression with Microsoft Azure's secure and scalable infrastructure services, including Ultra Disk Storage and Virtual Machines.
BELLEVUE, Wash., April 14, 2025 /PRNewswire/ - Viome Life Sciences, the leader in AI-powered, RNA-driven molecular diagnostics and precision nutrition, today launched its most transformative consumer product, redefining how individuals understand, track, and improve their health through evolving biological insights.
Viome's Full Body Intelligence Test™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's happening but why , and turns those insights into personalized daily nutrition advice to help you live healthier and longer., and turns those insights into personalized daily nutrition advice to help you live healthier and longer. Built on unique RNA science and cutting-edge AI, Viome's at-home test redefines health by analyzing 100 million biomarkers to detect early signs of biological dysfunction linked to 25+ chronic health conditions.BELLEVUE, Wash., April 14, 2025 /PRNewswire/ -- Viome Life Sciences, the leader in AI-powered, RNA-driven molecular diagnostics and precision nutrition, today launched its most transformative consumer product, redefining how individuals understand, track, and improve their health through evolving biological insights.Viome Launches AI-Powered Full Body Intelligence™ Test To Help You Stay Healthy, Slow Aging, and Make Illness OptionalAt the core of Viome's new experience is the radical idea that your genes are not your destiny, and your health outcomes are not static or predestined but measurable, modifiable, and within your control. Viome is the only company in the world that uses advanced RNA sequencing to decode your body's active gene expression and applies AI to translate that data into practical, daily health guidance. This includes what to eat, what to avoid, why you should eat certain foods, and how your personal health insights are connected to the most common diseases."Our medical industrial complex is reactive and waits until we experience symptoms or develop a disease instead of helping us stay healthy in the first place," said Naveen Jain, Founder and CEO of Viome. "Symptoms that we feel are the body's last cry for help
To run the new diagnostics division, Viome announced it has hired Kal Raman, most recently senior vice president of Non-Media Business, Marketing and Retail Technology at Amazon; before that he was Chief Digital Officer at Samsung and was formerly Chief Operating Officer at Groupon.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series D
Total Funding
$214M
Headquarters
Bellevue, Washington
Founded
2016
Find jobs on Simplify and start your career today